Delaqua Pharmaceuticals, Inc.
Chapel Hill, NC Doing business as Delaqua Pharmaceuticals Inc.
- UEI
- K8KTE53NVVL9
- CAGE
- 8ELG3
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 7016 Turkey Farm Rd, Chapel Hill, NC 27514, USA
- Website
- delaquapharma.com
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| P-GP inhibitor polymeric micelle platform for enhanced drug solubilization and oral bioavailability - abstract delaqua… | National Center for Advancing Translational Sciences | $322,184 | |
| Sbir phase i: triblock copolymer micelles for enhanced drug solubilization and stability -the broader… | National Science Foundation | $275,000 |
Quick answers
What is Delaqua Pharmaceuticals, Inc.'s UEI?
Delaqua Pharmaceuticals, Inc.'s Unique Entity ID (UEI) in SAM.gov is K8KTE53NVVL9.
What is Delaqua Pharmaceuticals, Inc.'s CAGE code?
Delaqua Pharmaceuticals, Inc.'s CAGE code is 8ELG3.
What is Delaqua Pharmaceuticals, Inc.'s primary NAICS code?
Delaqua Pharmaceuticals, Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Delaqua Pharmaceuticals, Inc. located?
Delaqua Pharmaceuticals, Inc.'s physical address in SAM.gov is 7016 Turkey Farm Rd, Chapel Hill, NC 27514, USA.
Is Delaqua Pharmaceuticals, Inc. registered in SAM.gov?
Yes. Delaqua Pharmaceuticals, Inc.'s SAM.gov registration is active through August 9, 2027.
What is Delaqua Pharmaceuticals, Inc.'s most recent federal award?
Delaqua Pharmaceuticals, Inc.'s most recent federal grant award is P-GP inhibitor polymeric micelle platform for enhanced drug solubilization and oral bioavailability - abstract delaqua… (R43TR005757), from National Center for Advancing Translational Sciences, on August 5, 2026.
On GovTribe
See Delaqua Pharmaceuticals, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors